Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Improved fibrosis staging by elastometry and blood test in chronic hepatitis C.

Calès P, Boursier J, Ducancelle A, Oberti F, Hubert I, Hunault G, de Lédinghen V, Zarski JP, Salmon D, Lunel F; ANRS HC EP 23 Fibrostar Study.

Liver Int. 2014 Jul;34(6):907-17. doi: 10.1111/liv.12327. Epub 2013 Oct 16.

PMID:
24102852
[PubMed - in process]
2.

A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.

Boursier J, de Ledinghen V, Zarski JP, Rousselet MC, Sturm N, Foucher J, Leroy V, Fouchard-Hubert I, Bertrais S, Gallois Y, Oberti F, Dib N, Calès P.

Am J Gastroenterol. 2011 Jul;106(7):1255-63. doi: 10.1038/ajg.2011.100. Epub 2011 Apr 5.

PMID:
21468012
[PubMed - indexed for MEDLINE]
3.

The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.

Boursier J, Vergniol J, Sawadogo A, Dakka T, Michalak S, Gallois Y, Le Tallec V, Oberti F, Fouchard-Hubert I, Dib N, Rousselet MC, Konaté A, Amrani N, de Ledinghen V, Calès P.

Liver Int. 2009 Nov;29(10):1507-15. doi: 10.1111/j.1478-3231.2009.02101.x. Epub 2009 Sep 2.

PMID:
19725892
[PubMed - indexed for MEDLINE]
4.

Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C.

Boursier J, Bertrais S, Oberti F, Gallois Y, Fouchard-Hubert I, Rousselet MC, Zarski JP, Calès P.

BMC Gastroenterol. 2011 Nov 30;11:132. doi: 10.1186/1471-230X-11-132.

PMID:
22129438
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Cirrhosis Diagnosis and Liver Fibrosis Staging: Transient Elastometry Versus Cirrhosis Blood Test.

Calès P, Boursier J, Oberti F, Bardou D, Zarski JP, de Lédinghen V; Multicentric Group.

J Clin Gastroenterol. 2014 May 13. [Epub ahead of print]

PMID:
24828359
[PubMed - as supplied by publisher]
6.

Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.

Boursier J, Bacq Y, Halfon P, Leroy V, de Ledinghen V, de Muret A, Bourlière M, Sturm N, Foucher J, Oberti F, Rousselet MC, Calès P.

Eur J Gastroenterol Hepatol. 2009 Jan;21(1):28-38. doi: 10.1097/MEG.0b013e32830cebd7. Review.

PMID:
19060630
[PubMed - indexed for MEDLINE]
7.

Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.

Calès P, Halfon P, Batisse D, Carrat F, Perré P, Penaranda G, Guyader D, d'Alteroche L, Fouchard-Hubert I, Michelet C, Veillon P, Lambert J, Weiss L, Salmon D, Cacoub P.

J Hepatol. 2010 Aug;53(2):238-44. doi: 10.1016/j.jhep.2010.03.007. Epub 2010 Apr 18.

PMID:
20493576
[PubMed - indexed for MEDLINE]
8.

Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C.

Calès P, de Ledinghen V, Halfon P, Bacq Y, Leroy V, Boursier J, Foucher J, Bourlière M, de Muret A, Sturm N, Hunault G, Oberti F.

Liver Int. 2008 Dec;28(10):1352-62. doi: 10.1111/j.1478-3231.2008.01789.x. Epub 2008 May 19.

PMID:
18492022
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.

Boursier J, de Ledinghen V, Zarski JP, Fouchard-Hubert I, Gallois Y, Oberti F, Calès P; multicentric groups from SNIFF 32, VINDIAG 7, and ANRS/HC/EP23 FIBROSTAR studies.

Hepatology. 2012 Jan;55(1):58-67. doi: 10.1002/hep.24654.

PMID:
21898504
[PubMed - indexed for MEDLINE]
10.

Two or more synchronous combination of noninvasive tests to increase accuracy of liver fibrosis assessement in chronic hepatitis C; results from a cohort of 446 patients.

Crisan D, Radu C, Lupsor M, Sparchez Z, Grigorescu MD, Grigorescu M.

Hepat Mon. 2012 Mar;12(3):177-84. doi: 10.5812/hepatmon.853. Epub 2012 Mar 28.

PMID:
22550525
[PubMed]
Free PMC Article
11.

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C.

Boursier J, Brochard C, Bertrais S, Michalak S, Gallois Y, Fouchard-Hubert I, Oberti F, Rousselet MC, Calès P.

Aliment Pharmacol Ther. 2014 Jul;40(2):178-88. doi: 10.1111/apt.12813. Epub 2014 Jun 2.

PMID:
24889599
[PubMed - in process]
12.

Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C.

Leroy V, Sturm N, Faure P, Trocme C, Marlu A, Hilleret MN, Morel F, Zarski JP.

J Hepatol. 2014 Jul;61(1):28-34. doi: 10.1016/j.jhep.2014.02.029. Epub 2014 Mar 11.

PMID:
24631902
[PubMed - in process]
13.

Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).

Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H, Bedossa P; FIBROSTIC study group.

J Hepatol. 2010 Dec;53(6):1013-21. doi: 10.1016/j.jhep.2010.05.035. Epub 2010 Aug 14.

PMID:
20850886
[PubMed - indexed for MEDLINE]
14.

Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.

Nguyen-Khac E, Chatelain D, Tramier B, Decrombecque C, Robert B, Joly JP, Brevet M, Grignon P, Lion S, Le Page L, Dupas JL.

Aliment Pharmacol Ther. 2008 Nov 15;28(10):1188-98. doi: 10.1111/j.1365-2036.2008.03831.x. Epub 2008 Aug 14.

PMID:
18705692
[PubMed - indexed for MEDLINE]
15.

Comparison of blood tests for liver fibrosis specific or not to NAFLD.

Calès P, Lainé F, Boursier J, Deugnier Y, Moal V, Oberti F, Hunault G, Rousselet MC, Hubert I, Laafi J, Ducluzeaux PH, Lunel F.

J Hepatol. 2009 Jan;50(1):165-73. doi: 10.1016/j.jhep.2008.07.035. Epub 2008 Oct 7.

PMID:
18977552
[PubMed - indexed for MEDLINE]
16.

FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.

Shaheen AA, Wan AF, Myers RP.

Am J Gastroenterol. 2007 Nov;102(11):2589-600. Epub 2007 Sep 10. Review.

PMID:
17850410
[PubMed - indexed for MEDLINE]
17.

[Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B].

Chen XB, Zhu X, Chen LY, Chen EQ, Tang H.

Zhonghua Gan Zang Bing Za Zhi. 2011 Apr;19(4):286-90. doi: 10.3760/cma.j.issn.1007-3418.2011.04.013. Chinese.

PMID:
21586228
[PubMed - indexed for MEDLINE]
18.

Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B.

Goyal R, Mallick SR, Mahanta M, Kedia S, Shalimar, Dhingra R, Sharma H, Das P, Datta Gupta S, Panda S, Acharya SK.

J Gastroenterol Hepatol. 2013 Nov;28(11):1738-45. doi: 10.1111/jgh.12318.

PMID:
23808910
[PubMed - indexed for MEDLINE]
19.

Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C.

Zarski JP, Sturm N, Guechot J, Zafrani ES, Vaubourdolle M, Thoret S, Margier J, David-Tchouda S, Bosson JL.

PLoS One. 2013;8(3):e59088. doi: 10.1371/journal.pone.0059088. Epub 2013 Mar 21.

PMID:
23555619
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.

Stevenson M, Lloyd-Jones M, Morgan MY, Wong R.

Health Technol Assess. 2012;16(4):1-174. doi: 10.3310/hta16040. Review.

PMID:
22333291
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk